Kim Papp

Probity Medical

Dr Kim Papp MD, PhD, F.R.C.P.C is the founder and President of Probity Medical Research Inc., an organisation that guides the conduct of clinical researchers. He received his Doctor of Medicine degree from the University of Calgary Medical School and was a resident in internal Medicine and Dermatology at the University of Toronto. Over the past 15 years, Dr Papp has conducted more than 220 clinical trials and followed over 3,000 subjects.  He has authored or co-authored more than 250 publications and abstracts and has invesitgated over 50 unique compounds in development for the treatment of psoriasis.



E-Posters by Kim Papp
PASI response among guselkumab patients who did not achieve PASI 90 after retreatment in voyage 2 trial
PASI response among guselkumab patients who did not achieve PASI 90 after retreatment in voyage 2 trial
K. Papp, S. Fakharzadeh, M. Song, Y.-K. Shen, Y. You, A. Freiman, B.-S. Kim, J.J. Wu, D. Thaci